ArticleOncology reports2022
miRNA‑218 targets multiple oncogenes and is a therapeutic target for osteosarcoma.
Kentaro Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleOncology reports2022
Kentaro Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.